Mavrilimumab (CAM 3001) is a monoclonal antibody that binds to the alpha subunit of the granulocyte-macrophage colony stimulating factor (GM-CSF) receptor and blocks intracellular signalling downstream of GM-CSF. GM-CSF might be a mediator of the hyperactive inflammatory response associated with respiratory failure and death.
Reinheit:
98.0%
CAS Nummer:
[1085337-57-0]
Target-Kategorie:
CSF-1R (c-Fms)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
